Zhang L J, Xu Z M, Yang F, Dang H, Li Y L, Lü S, Cao C L, Xu J, Li S Z, Zhou X N
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research); NHC Key Laboratory of Parasite and Vector Biology; WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Shanghai 200025, China.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2021 Jun 22;33(3):225-233. doi: 10.16250/j.32.1374.2021109.
This report presented the endemic status of schistosomiasis in the People's Republic of China at a national level in 2020, and analyzed the data collected from the national schistosomiasis prevention and control system and national schistosomiasis surveillance sites. Among the 12 provinces (municipality and autonomous region) endemic for schistosomiasis in China, Shanghai Municipality, Zhejiang Province, Fujian Province, Guangdong Province and Guangxi Zhuang Autonomous Region continued to consolidate the achievements of schistosomiasis elimination, and Sichuan and Jiangsu provinces maintained the criteria of transmission interruption, while Yunnan, Hubei, Anhui, Jiangxi and Hunan provinces maintained the criteria of transmission control by the end of 2020. A total of 450 counties (cites, districts) were found to be endemic for schistosomiasis in China, with 28 376 endemic villages covering 71 370 400 people at risk of infections. Among the 450 endemic counties (cities, districts), 74.89% (337/450), 21.87% (98/450) and 3.33% (15/450) achieved the criteria of elimination, transmission interruption and transmission control of schistosomiasis, respectively. By the end of 2020, 29 517 cases with advanced schistosomiasis were documented in China. In 2020, 11 117 655 individuals received inquiry examinations and 1 798 580 were positive; 5 263 082 individuals received serological tests and 83 179 were sero-positive. A total of 273 712 individuals received stool examinations and 3 were positive, including one case of acute schistosomiasis. In 2020, snail survey was performed in 19 733 endemic villages in China and snails were found in 7 309 villages, accounting for 37.04% of all surveyed villages, with 15 villages identified with emerging snail habitats. Snail survey covered an area of 736 984.13 hm and 206 125.22 hm snail habitats were found, including 1 174.67 hm emerging snail habitats and 1.96 hm habitats with infected snails. In 2020, 544 424 bovines were raised in the schistosomiasis-endemic areas of China, and 147 887 received serological examinations, with 326 positives detected, while 130 673 bovines received stool examinations, with no positives identified. In 2020, there were 19 214 patients with schistosomiasis receiving praziquantel chemotherapy, and 964 103 person-time individuals and 266 280 herd-time bovines were given expanded chemotherapy. In 2020, molluscicide treatment was performed in 136 141.92 hm snail habitats, and the actual area of chemical treatment was 71 980.22 hm, while environmental improvements were performed in snail habitats covering an area of 1 464.03 hm. Data from the national schistosomiasis surveillance sites of China showed that the mean prevalence of infections were both zero in humans and bovines in 2020, and no infection was detected in snails. The results demonstrate that the overall endemic status of schistosomiasis remains at a low level in China and the goal of the was achieved as scheduled; however, the endemic situation of schistosomiasis rebounded in local areas. Precision schistosomiasis control and intensified monitoring of the endemic situation and transmission risk of schistosomiasis are required to be performed to facilitate the progress towards elimination of schistosomiasis steadily.
本报告介绍了2020年中华人民共和国全国层面的血吸虫病流行状况,并对全国血吸虫病防治系统和全国血吸虫病监测点收集的数据进行了分析。在中国血吸虫病流行的12个省(直辖市、自治区)中,上海市、浙江省、福建省、广东省和广西壮族自治区继续巩固血吸虫病消除成果,四川省和江苏省维持传播阻断标准,而云南省、湖北省、安徽省、江西省和湖南省截至2020年底维持传播控制标准。中国共有450个县(市、区)有血吸虫病流行,有28376个流行村,涉及7137.04万感染风险人群。在450个血吸虫病流行县(市、区)中,分别有74.89%(337/450)、21.87%(98/450)和3.33%(15/450)达到血吸虫病消除、传播阻断和传播控制标准。截至2020年底,中国登记在册的晚期血吸虫病病例有29517例。2020年,1111.7655万人接受询检,179.